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Abstract Expression of the liver-type isopeptides of cytochrome 
c oxidase is regulated post-transcriptionally. An RNA-binding 
activity has been found in only those cells where the liver-type 
subunits are detected. This binding protein, termed COLBP, 
recognises equences or structures within the 3'-untranslated re- 
gions of transcripts encoding these liver-type isopeptides and has 
been implicated in the modulation of mRNA expression. We now 
show by subcellular fractionation, immunocompetition, UV- 
crosslinking and shift-Western studies that the metabolic enzyme 
glutamate dehydrogenase, previously reported as being able to 
bind RNA, is the cytochrome c oxidase transcript-binding pro- 
tein, COLBP. 
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1. Introduction 
The expression of many mRNA species is regulated by pro- 
teins binding to sequences or structures within those tran- 
scripts. These binding sites, or response elements, are often 
located in mRNA untranslated regions and interaction with 
trans-acting binding factors may impart rapid degradation, sta- 
bilization or translational silencing of the bound mRNA [1-3]. 
We are currently investigating the mechanisms underlying the 
post-transcriptional regulation of the liver-type isoforms of cy- 
tochrome c oxidase (COX). Several subunits of mammalian 
COX are found as either one of two tissue-specific soforms 
referred to as either the heart (H-) or liver (L-) type [4,5]. 
Numerous reports have shown that whereas the H-isotypes are 
regulated at the level of transcription, the L-type transcripts are 
present at varying levels in all tissues, irrespective of the isopep- 
tide's presence in the enzyme complex [6-10]. Using radiola- 
belled COX L-type transcripts as substrates, we recently dem- 
onstrated, both by gel mobility shift and UV-crosslinking anal- 
yses, the formation of an RNA-protein complex in cell lysates 
from only those cell types where the L-type isopeptides are 
detected [11]. This binding protein has therefore been impli- 
cated in regulating mRNA expression possibly by increasing 
mRNA stability. In support of this hypothesis, we also ob- 
served that mitochondrial stress causes a concomitant increase 
in COX L-type transcript stability and binding protein activity 
[12]. Attempts to isolate the binding protein (termed COLBP 
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or cytochrome c oxidase L-form transcript-binding protein) 
were initially complicated by the appearance, after ion ex- 
change chromatography, of a second binding complex with a 
lower mobility on nondenaturing gels. Purification and protein 
sequence data assigned this second activity to glutamate dehy- 
drogenase [13]. Competition assays howed the enzyme did not 
bind homoribopolymers, single stranded DNA or tRNA. 
Using a combination of subcellular fractionation, immuno- 
competition, UV-crosslinking and shift-Western studies we 
now show that there is only one identifiable COX L-type tran- 
script binding protein, the mitochondrial matrix enzyme gluta- 
mate dehydrogenase. 
2. Materials and methods 
2.1. Preparation and subfractionation of mitochondria and measurement 
of enzyme activities 
Mitochondria were prepared from fresh liver tissue by homogeniza- 
tion and differential centrifugation using STE (250 mM sucrose, 2mM 
EDTA, 10 mM Tris(Cl), pH 7.4, 0.5 mM DTT/PMSF) as medium. For 
the final wash, mitochondria were resuspended in STE binding buffer 
(STEBB; as STE but 0.2 mM EDTA, 40 mM NaCI, 2 mM MgCI2), 
Samples of homogenate and postmitochondrial supernatant were dial- 
ysed against STEBB or standard binding buffer (SBB; 20 mM Tris(Cl), 
pH 7.6, 0.2 mM EDTA, 40 mM NaC1, 2 mM MgCI2, 10% glycerol (v/v), 
0.5 mM DTT/PMSF). Equal volumes of 1.5% (w/v) digitonin and 
mitochondrial suspension atvarious protein concentrations i  STEBB 
were mixed on ice followed by 3-fold dilution after 15 rain. Mitoplasts 
were pelleted, and suspended with STEBB, 1% Triton X-100 (v/v) in 
a volume proportional tothe starting amount of mitochondrial protein. 
Supernatants were concentrated accordingly before adding Triton X- 
100 to 1% (v/v). Mitochondrial proteins were separated into soluble and 
integral membrane proteins by means of the temperature-induced phase 
separation i  Triton X-114 [14]. Enzymatic activities were measured 
spectrophotometrically essentially as described [15 17]. For modified 
GMS-assay, the prepared mitochondria n STEBB were checked for 
integrity by oxygen electrode measurement [18] and respiratory control 
ratios were routinely between 3-5. 
2.2. Preparation of 3:P-labelled COX L-type transcripts, S-IO0 cytosolic 
extracts, and gel mobility shift analyses 
High specific activity 32P-labelled RNA was transcribed from fin- 
earised plasmids pCOL8-356, pBSF3-2 or pCOX7a.22 as previously 
described [11,13,19] using an in vitro transcription kit (Stratagene). In
this way, 5'-truncated bovine COX subunit VIII-L (BCOL8), and VIIa- 
L (BCOL7a), or full-length uman COX subunit VIIa-L (HCOL7a) 
transcripts were produced. Preparation of bovine liver S-100 eytosolic 
extracts and standard GMS-analysis were essentially as previously de- 
scribed [13]. Protein preparations were incubated with 32p-labelled 
COX L-type transcripts in the presence of poly(A) and -(C) (2.5 ,ug 
each), and 1% (v/v) Triton X-100 (Fig. 1 only). Binding mixtures (10 
¢tl) were based on STEBB or SBB, and were resolved by non-denaturing 
4% PAGE. Quantitation of binding complex intensity was by 
PhosphorImager analysis using ImageQuant software (Molecular Dy- 
namics). 
Binding of RNA to intact mitoehondria was analysed as follows. 
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Fig. 1. COX L-type transcript binding protein behaves as a soluble mitochondrial matrix protein. (A) Homogenate (horn), postmitochondrial 
supernatant (pms), and mitochondrial fraction (mit) from bovine liver tissue were analysed for monoamine oxidase (mao), citrate synthase (cs), and 
glutamate dehydrogenase (gdh) activities, as well as RNA-binding (RNA-bdg). GMS-assays of these fractions using 32P-labelled BCOL7a as substrate 
are shown (inset, lanes 3-8), alongside purified gdh (lane 1) and S-100 extract (lane 2) for comparison. Protein amounts used are stated above the 
lanes in/zg. The bar chart gives the activities per protein mass relative to the homogenate. (B) Digitonin-treated mitoplast pellets (lanes 1-4) and 
corresponding supernatants (lanes 5-8), equivalent to 190/zg mitochondrial protein, were analysed by GMS-assay with 32p-labelled BCOL7a as 
substrate. The digitonin to protein ratio used is indicated above the lanes. Fractions were also assayed for marker enzyme activities (adenylate kinase; 
ak) and RNA-binding. The fraction of activity remaining in the mitochondrial pellet is displayed as % of total. (C) Aliquots, corresponding to 60 
/lg protein, of aqueous upernatant (SN; lane 1) and detergent-rich pellet (P; lane 2) derived from Triton X-114 treatment of bovine mitochondria 
were analysed by GMS-assay using 32p-labelled HCOL7a as substrate. 
Mitochondrial preparations in STEBB were preincubated for 5 min on 
ice with poly(A) and -(C) (8 or 25/lg each), and binding reactions with 
32p-labelled RNA (500,000 cpm) were carried out at room temperature 
for 15 min. Consecutive treatment with RNase T1 (40 or 100 units) and 
heparin (100 or 250/lg) was for 5 min each at room temperature. Triton 
X-100 (0.45% v/v) was added to the reactions at the indicated stages 
during the incubation and the solutions (final volume 55/11) gently 
mixed until homogeneous. Analysis by non-denaturing PAGE was as 
given above. Mitochondrial integrity during the procedure was moni- 
tored by centrifuging control incubations and assaying enzyme activi- 
ties in mitochondrial pellet and supernatant. 
2.3. Production of anti-gdh ant&era, affinity purified antibodies, shift- 
Western blotting and irnmunoprecipitation 
Rabbits were inoculated subcutaneously with 8.9 nmol bovine gluta- 
mate dehydrogenase (Sigma Type VI) in 500 /xl of 1:1 phosphate 
buffered saline/Freund's complete adjuvant. Three equimolar boost 
inocula with incomplete adjuvant were performed over a two-month 
period before exsanguination after four months. Affinity purification 
of anti-gdh antibodies was achieved using glutamate dehydrogenase 
immobilized on CNBr-sepharose 4-B (Sigma) following standard tech- 
niques. For shift-Western analysis, an adaptation of procedures pub- 
lished for DNA-binding proteins [20,21] was employed. Standard 
GMS-assays were performed with S-100 extract. The wet gel was ex- 
posed to a PhosphorImager screen before transfer to Immobilon-P 
membrane (Pharmacia) nd hybridization with polyclonal anti-gdh an- 
tisera. Radiolabelled RNA was not retained on the membrane after 
transfer. Detection of bound antibody was by enhanced chemilumines- 
cence (ECL-kit, Amersham). 
For immunoprecipitation, GMS assays were performed with S-100 
extract in SBB buffered with triethanolamine (50 mM; pH 7.6) after a 
preclearing step with protein-A agarose (Sigma). The reactions were 
UV-irradiated for 20 rain at room temperature (UV-Stratalinker 2400, 
Stratagene), followed by digestion with 6 pg RNase A for 10 min at 
room temperature. Samples were then diluted to 50/tl with PBS, added 
to antibodies prebound to protein-A agarose (3 ~tl bead volume), and 
incubated, rotating, for 2 h at 4°C. After removal of the supernatant, 
the agarose beads were washed and resuspended in PBS. Supernatants 
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Fig. 2. Anti-gdh antibodies recogmze COLBP and compete for complex formation. (A) Bovine liver mitochondrial protein (25/zg) was resolved by 
10% SDS-PAGE and blotted to Immobilon-P membrane. A single immunoreactive band was detected with anti-gdh antisera (1:200 v/v). Positions 
of prestained molecular weight markers are indicated. (B) S-100 extract protein (50/.tg) was preincubated with 115/zg polyclonal nti-gdh antisera 
(lane 3), or 140/zg preimmune s ra (lane 4) for 10 min at 25°C, followed by GMS-assay using 32p-labelled HCOL7a as substrate. A control without 
serum addition (lane 2), and untreated RNA (lane 1) are also shown. (C) Purified glutamate dehydrogenase (5/zg, lane 8) or S-100 extract (200/~g) 
were incubated with BCOL7a as per GMS-analysis and subjected toUV-crosslinking and RNase A digestion. Samples were immunoprecipitated 
with: 6.5/~g affinity purified anti-gdh antibody (apa; lanes 6, 7), 320/lg anti-gdh antisera (lanes 4, 5) or preimmune s rum (lanes 2, 3). Pellets (P) 
and supernatants (SN) were subjected to 10% SDS-PAGE. A control incubation without immunoprecipitation (5/~g dh, lane 8) is also shown. 
(D) S-100 extract protein (50/zg; lanes 2, 3 or 100/lg; lanes 4-8) were preincubated with 1 mM of the indicated nucleotide(s) for10 rain on ice followed 
by GMS-assay using BCOL7a as substrate. Control incubations without 32p-labelled RNA (lanes 2, 3) and/or nucleotide addition (lanes 2, 4) are 
also shown, as is the mobility of untreated RNA (lane 1). The left panel (RNA) shows the radioactive image of the gel. The right panel (protein) 
represents the immunoblot f the same gel using anti-gdh antisera. 
and the bead-bound proteins were subjected to 10% SDS-PAGE, fol- 
lowed by PhosphorImager analysis. 
3. Results and discussion 
We previously demonstrated that purified bovine glutamate 
dehydrogenase could form a complex with COX L-type tran- 
scripts [13]. A different electrophoretic mobility was noted for 
the RNA-protein complex observed with S-100 extract, sug- 
gesting the extract contained a distinct RNA-binding protein, 
the as yet unidentified COLBR In an attempt to study COLBP 
in the absence of glutamate dehydrogenase, the mitochondrial 
enzyme was removed by subcellular fractionation of bovine 
liver tissue. Surprisingly, as illustrated in Fig. 1A, COLBP ac- 
tivity was found only in the mitochondrial fraction. To detect 
the submitochondrial location of this activity, the outer mito- 
chondrial membrane was selectively solubilized with digitonin. 
Matrix (gdh), intracristal space (ak) and outer membrane (mao) 
markers were assayed as detailed in the legend to Fig. 1 B. Even 
after release of 81% adenylate kinase and 70% monoamine 
oxidase, COLBP activity remained with the mitoplasts. The 
solubility of proteins in Triton X-114 is routinely used to con- 
firm their integral membrane nature. The detergent liberates all 
binding activity into the aqueous phase (Fig. l C). Thus, all the 
cytoplasmic RNA-binding activity is limited to the mitochon- 
drial fraction and the binding protein behaves like a soluble 
mitochondrial matrix protein. 
Glutamate dehydrogenase and COLBP clearly colocalize, 
but on non-denaturing gels the RNA-protein complex formed 
with purified glutamate dehydrogenase exhibits a decreased 
mobility (Fig. 1A). Furthermore, only the faster migrating 
binding-complex is resolved using mitochondrial extracts. As- 
suming lutamate dehydrogenase was synonymous with or in- 
tegral to COLBP, the discrepancy in mobility could be due to 
the following: a difference in conformation, differential protec- 
tion of the bound RNA molecule against RNase T1, an in- 
creased charge density due to post-translational modification 
or interactions with small, acidic molecules such as cardiolipin 
which may be lost during purification of the enzyme. To test 
whether COLBP was, or contained glutamate dehydrogenase, 
polyclonal antibodies were prepared against bovine glutamate 
dehydrogenase (Fig. 2A). Formation of any detectable RNA- 
protein complex was prevented by preincubation f S-100 ex- 
tract (Fig. 2B, lane 3) or purified enzyme with anti-gdh antisera 
(data not shown), but was unaffected by similar amounts of 
preimmune serum (lane 4). We have previously demonstrated 
294 Z Preiss et al./FEBS Letters 367 (1995) 291-296 
A 
®®® ® 
!/] . . . . . ,  
TX T1 
4. 
T1 1~1 4. RNA ~t 
4. 4. 
* 4. 
TX H 
. ® ® ® ® c 
free 
.¢ 
free 
® ® ®® 
-¢  
i 1 2 3 4 5 6 7 8 9 I i l  ' 3 , , e ? 8 o l  
D RNA protein 
+BCOL7a 
I z (9 T r3 
+BCOLTa 
°I 
free 
I1  2 3 4 5 6 ~ e l l1  2 3 4 5 e ? 81  
Fig. 3. Glutamate dehydrogenase in intact mitochondria can interact with exogenously added COX transcripts. Formation of RNA glutamate 
dehydrogenase complexes was assayed with intact mitochondria prepared from either bovine or rat liver. (A) Schematic representation indicating 
order (a, b, c or d) of component addition (M = mitochondria; RNA = 32p-labelled COX L-type RNA; TI = RNase T1; H = heparin; TX = Triton 
X-100). (B) Bovine liver mitochondria (100/lg, lanes 2, 6; 300 pg, lanes 3, 7; or 500 pg protein, lanes 4, 5, 8, 9) were incubated with 3zp-labelled BCOL8 
as snbstrate. The order of addition of all reaction components is indicated above the lanes (cf. A). Recovery of mitochondria from a control incubation 
(scheme b without 32p-labelled RNA) showed loss of 3.8% gdh-, and 2.1% ak activity. No loss of mao was measurable. (C) GMSanalysis with rat 
liver mitochondrial preparations (100,ug, lanes 2, 5; 300 pg, lanes 3, 6; 500 pg 4, 7-9) as in B, but using 32p-labelled BCOL7a as substrate. The control 
incubation according to scheme b showed loss of 1.2% gdh- and 3.7% ak activity. 
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that COLBP can be visualized by SDS-PAGE after UV- 
crosslinking to 32p-labelled COX mRNAs and RNase digestion 
[11]. After similar treatment of S-100 extract or purified gluta- 
mate dehydrogenase, a protein of identical size is observed (Fig. 
2C, lanes 1,8). This protein can be immunoprecipitated from 
liver homogenate by affinity-purified anti-gdh antibodies (lanes 
6,7). 
Further evidence for glutamate dehydrogenase and COLBP 
being identical proteins was provided by shift-Western analysis. 
Bovine liver extract and radiolabelled BCOL7a transcript were 
mixed and subjected to GMS-analysis as detailed in the legend 
to Fig. 2D. Complex formation was initially identified by 
PhosphorImager analysis of the wet gel (Fig. 2D, left panel), 
after which the protein was transferred to a membrane and 
assayed by standard Western blotting with anti-gdh antisera 
(right panel). The immunoreactive and radiolabelled band 
clearly co-migrates (cf. lane 4, left and right panels). Glutamate 
dehydrogenase activity is known to be regulated by several 
nucleotide ffectors [22], levels of which fluctuate dependent on 
the energy state of the mitochondria. Shift Western analysis of 
liver S-100 extracts assayed for RNA-binding in the presence 
of several effectors hows that binding is inhibited by a combi- 
nation of 1 mM GTP and NADH but by neither independently 
(lanes 6-8). A partial inhibition of complex formation in the 
presence of lmM ADP was also consistently noted (lane 5). As 
the formation of large concentration-dependent mul ipolymer 
species of glutamate dehydrogenase can be induced by varying 
effector levels [23], it was a formal possibility that the absence 
of complex formation with the combination of GTP and 
NADH may have been caused by generating these mul- 
tipolymer species. Western analysis, however, revealed that the 
absence of complex formation in lmM GTP/NADH was not 
due to decreasing levels of the binding species (right panel, lane 
8). 
Taking the data presented in Figs. 1 and 2, we conclude that 
only one protein can be shown to interact with the 3'-untrans- 
lated region of the COX L-type transcripts and that this protein 
is glutamate dehydrogenase. The mutually exclusive subcellular 
locations for these mRNAs and glutamate dehydrogenase seem 
incompatible with an in vivo interaction and consequently with 
any role in transcript protection or expression. Clearly, the 
binding species cannot be the precursor form of glutamate 
dehydrogenase as it is not found in the cytosol (Fig. 1A) and 
is of identical size to the mature nzyme after denaturing PAGE 
(Fig. 2C). It is, however, an intriguing observation that, in vitro, 
transcripts encoding mitochondrially-destined peptides can 
bind to a protein found within the target organelle. Is it possible 
that these nuclear-encoded transcripts are accessible to a subset 
of glutamate dehydrogenase molecules? Previous biochemical 
and immunohistochemieal data, demonstrating two distinct mi- 
tochondrial matrix locations for glutamate dehydrogenase, one 
soluble and one membrane associated, is consistent with this 
hypothesis [24,25]. 
To assess this possibility, bovine and rat liver mitochondria 
were prepared and transcript binding was assayed with intact 
mitochondria s detailed in section 2.2. RNase Tl/heparin- 
insensitive RNA-protein complexes formed on addition of ra- 
diolabelled substrate to the intact organelles, whilst RNase T1 
pretreatment of the substrate before mitochondrial addition 
prevented complex formation (Fig. 3). No increase in complex 
formation could be achieved by presolubilization of the mito- 
chondria (Fig. 3; cf. conditions c and a). The data shown is 
representative of numerous experiments with independent mi- 
tochondrial preparations. Binding was not lost after solubiliza- 
tion of the outer membrane or by salt washing the organelles 
(data not shown), indicating that glutamate dehydrogenase lib-
erated from partially lysed mitochondria during homogenisa- 
tion had not simply become associated with the outer mito- 
chondrial membrane of the intact organelles. 
This preliminary data is intriguing. Several recent reports 
have restated the probability that some mitochondrially-des- 
tined polypeptides are cotranslationally translocated [26,27]. 
Taken in tandem with the effector studies and our recent obser- 
vation that RNA-binding requires phosphorylation of gluta- 
mate dehydrogenase (Preiss et al., manuscript in preparation), 
it is possible that a subset of transcripts encoding mitochondri- 
ally destined polypeptides may be localized to the mitochon- 
drial periphery by a regulated interaction with the RNA-bind- 
ing domain at membrane contact sites. Once bound, transcripts 
may be stabilized, and translation products cotranslationally 
translocated. Alternatively, interactions between glutamate de- 
hydrogenase and its substrate mRNAs may function to keep 
the polysome anchored to the mitochondrial periphery once the 
nascent peptide has been fully translocated. This could be of 
particular importance for short peptides uch as the COX sub- 
units which may be not be large enough to maintain polysomal 
anchoring during cotranslational translocation. 
In conclusion, we have demonstrated that the resolvable 
complexes formed between COX L-type transcripts and cyto- 
plasmic protein all contain the mitochondrial matrix protein 
glutamate dehydrogenase. The interaction of a nuclear-derived 
mRNA and a mitochondrial protein may seem paradoxical; 
however, our preliminary data suggests that the RNA-binding 
domain of mammalian glutamate dehydrogenase may be ac- 
cessible to the cytosol. Further experimentation is currently 
underway to resolve the physiological relevance of this inter- 
action. 
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